Your browser doesn't support javascript.
loading
Anti-CXCL4 Antibody Reactivity Is Present in Systemic Sclerosis (SSc) and Correlates with the SSc Type I Interferon Signature.
Lande, Roberto; Mennella, Anna; Palazzo, Raffaella; Pietraforte, Immacolata; Stefanantoni, Katia; Iannace, Nicoletta; Butera, Alessia; Boirivant, Monica; Pica, Roberta; Conrad, Curdin; Chizzolini, Carlo; Riccieri, Valeria; Frasca, Loredana.
Afiliação
  • Lande R; Istituto Superiore di Sanita', National Centre for Pre-Clinical and Clinical Drug Research and Evaluation, Pharmacological Research and Experimental Therapy Unit, 00166 Rome, Italy.
  • Mennella A; Istituto Superiore di Sanita', National Centre for Pre-Clinical and Clinical Drug Research and Evaluation, Pharmacological Research and Experimental Therapy Unit, 00166 Rome, Italy.
  • Palazzo R; Department of Dermatology, University Hospital CHUV, 1011 Lausanne, Switzerland.
  • Pietraforte I; Istituto Superiore di Sanita', National Centre for Pre-Clinical and Clinical Drug Research and Evaluation, Pharmacological Research and Experimental Therapy Unit, 00166 Rome, Italy.
  • Stefanantoni K; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, 00161 Rome, Italy.
  • Iannace N; Division of Rheumatology, Internal Medicine and Medical Specialties, University La Sapienza, 00185 Rome, Italy.
  • Butera A; Division of Rheumatology, Internal Medicine and Medical Specialties, University La Sapienza, 00185 Rome, Italy.
  • Boirivant M; Istituto Superiore di Sanita', National Centre for Pre-Clinical and Clinical Drug Research and Evaluation, Pharmacological Research and Experimental Therapy Unit, 00166 Rome, Italy.
  • Pica R; Istituto Superiore di Sanita', National Centre for Pre-Clinical and Clinical Drug Research and Evaluation, Pharmacological Research and Experimental Therapy Unit, 00166 Rome, Italy.
  • Conrad C; Sandro Pertini Hospital, IBD, GE Unit, 00157 Rome, Italy.
  • Chizzolini C; Department of Dermatology, University Hospital CHUV, 1011 Lausanne, Switzerland.
  • Riccieri V; Immunology & Allergy and Immunology & Pathology Dept., University Hospital and School of Medicine, CH-1211 Geneva, Switzerland.
  • Frasca L; Division of Rheumatology, Internal Medicine and Medical Specialties, University La Sapienza, 00185 Rome, Italy.
Int J Mol Sci ; 21(14)2020 Jul 19.
Article em En | MEDLINE | ID: mdl-32707718
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Escleroderma Sistêmico / Autoanticorpos / Fator Plaquetário 4 / Interferon Tipo I Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Mol Sci Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Escleroderma Sistêmico / Autoanticorpos / Fator Plaquetário 4 / Interferon Tipo I Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Mol Sci Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Itália